Funding agencies: This study was supported by Otsuka Pharmaceutical Company, Ltd. Financial support was provided by Otsuka Pharmaceutical Company, Ltd. for editorial assistance in the preparation of the article.
Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
Article first published online: 25 JUN 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 28, Issue 10, pages 1447–1450, September 2013
How to Cite
Mizuno, Y., Nomoto, M., Kondo, T., Hasegawa, K., Murata, M., Takeuchi, M., Ikeda, J., Tomida, T., Hattori, N. and on behalf of the Rotigotine Trial Group (2013), Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Mov. Disord., 28: 1447–1450. doi: 10.1002/mds.25537
Relevant conflicts of interest/financial disclosures: J.I. and T.T. are employees of Otsuka Pharmaceutical Company, Ltd.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 23 SEP 2013
- Article first published online: 25 JUN 2013
- Manuscript Accepted: 3 APR 2013
- Manuscript Revised: 25 MAR 2013
- Manuscript Received: 18 NOV 2012
Additional Supporting Information may be found in the online version of this article.
|mds25537-sup-0002-supptabs.doc||55K||Supporting Information Tables 1 and 2.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.